# Drug Interaction and Food Effect Study of CS0159

> **NCT07429331** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Cascade Pharmaceuticals, Inc** · enrollment: 32 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** CS0159 Tablet
- **DRUG:** Rifampicin Capsule
- **DRUG:** Itraconazole Capsule

## Key facts

- **NCT ID:** NCT07429331
- **Lead sponsor:** Cascade Pharmaceuticals, Inc
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07429331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07429331, "Drug Interaction and Food Effect Study of CS0159". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07429331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*